Global Parkinson's Disease Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Parkinson's Disease market size was valued at US$ million in 2023. With growing demand in downstream market, the Parkinson's Disease is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Parkinson's Disease market. Parkinson's Disease are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Parkinson's Disease. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Parkinson's Disease market.
Key Features:
The report on Parkinson's Disease market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Parkinson's Disease market. It may include historical data, market segmentation by Type (e.g., Carbidopa/Levodopa, Dopamine Receptor Agonists), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Parkinson's Disease market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Parkinson's Disease market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Parkinson's Disease industry. This include advancements in Parkinson's Disease technology, Parkinson's Disease new entrants, Parkinson's Disease new investment, and other innovations that are shaping the future of Parkinson's Disease.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Parkinson's Disease market. It includes factors influencing customer ' purchasing decisions, preferences for Parkinson's Disease product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Parkinson's Disease market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Parkinson's Disease market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Parkinson's Disease market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Parkinson's Disease industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Parkinson's Disease market.
Market Segmentation:
Parkinson's Disease market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Parkinson's Disease market size was valued at US$ million in 2023. With growing demand in downstream market, the Parkinson's Disease is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Parkinson's Disease market. Parkinson's Disease are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Parkinson's Disease. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Parkinson's Disease market.
Key Features:
The report on Parkinson's Disease market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Parkinson's Disease market. It may include historical data, market segmentation by Type (e.g., Carbidopa/Levodopa, Dopamine Receptor Agonists), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Parkinson's Disease market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Parkinson's Disease market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Parkinson's Disease industry. This include advancements in Parkinson's Disease technology, Parkinson's Disease new entrants, Parkinson's Disease new investment, and other innovations that are shaping the future of Parkinson's Disease.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Parkinson's Disease market. It includes factors influencing customer ' purchasing decisions, preferences for Parkinson's Disease product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Parkinson's Disease market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Parkinson's Disease market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Parkinson's Disease market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Parkinson's Disease industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Parkinson's Disease market.
Market Segmentation:
Parkinson's Disease market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Carbidopa/Levodopa
- Dopamine Receptor Agonists
- MAO-Inhibitors
- Hospitals
- Clinics
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Teva
- Novartis
- GSK
- AbbVie
- Merck
- Boehringer Ingelheim
- Amneal + Impax
- Lundbeck
- Sun Pharma
- Wockhardt
- UCB
- Bausch Health
- Acadia
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Parkinson's Disease Market Size 2019-2030
2.1.2 Parkinson's Disease Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Parkinson's Disease Segment by Type
2.2.1 Carbidopa/Levodopa
2.2.2 Dopamine Receptor Agonists
2.2.3 MAO-Inhibitors
2.3 Parkinson's Disease Market Size by Type
2.3.1 Parkinson's Disease Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Parkinson's Disease Market Size Market Share by Type (2019-2024)
2.4 Parkinson's Disease Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.5 Parkinson's Disease Market Size by Application
2.5.1 Parkinson's Disease Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Parkinson's Disease Market Size Market Share by Application (2019-2024)
3 PARKINSON'S DISEASE MARKET SIZE BY PLAYER
3.1 Parkinson's Disease Market Size Market Share by Players
3.1.1 Global Parkinson's Disease Revenue by Players (2019-2024)
3.1.2 Global Parkinson's Disease Revenue Market Share by Players (2019-2024)
3.2 Global Parkinson's Disease Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PARKINSON'S DISEASE BY REGIONS
4.1 Parkinson's Disease Market Size by Regions (2019-2024)
4.2 Americas Parkinson's Disease Market Size Growth (2019-2024)
4.3 APAC Parkinson's Disease Market Size Growth (2019-2024)
4.4 Europe Parkinson's Disease Market Size Growth (2019-2024)
4.5 Middle East & Africa Parkinson's Disease Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Parkinson's Disease Market Size by Country (2019-2024)
5.2 Americas Parkinson's Disease Market Size by Type (2019-2024)
5.3 Americas Parkinson's Disease Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Parkinson's Disease Market Size by Region (2019-2024)
6.2 APAC Parkinson's Disease Market Size by Type (2019-2024)
6.3 APAC Parkinson's Disease Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Parkinson's Disease by Country (2019-2024)
7.2 Europe Parkinson's Disease Market Size by Type (2019-2024)
7.3 Europe Parkinson's Disease Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Parkinson's Disease by Region (2019-2024)
8.2 Middle East & Africa Parkinson's Disease Market Size by Type (2019-2024)
8.3 Middle East & Africa Parkinson's Disease Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PARKINSON'S DISEASE MARKET FORECAST
10.1 Global Parkinson's Disease Forecast by Regions (2025-2030)
10.1.1 Global Parkinson's Disease Forecast by Regions (2025-2030)
10.1.2 Americas Parkinson's Disease Forecast
10.1.3 APAC Parkinson's Disease Forecast
10.1.4 Europe Parkinson's Disease Forecast
10.1.5 Middle East & Africa Parkinson's Disease Forecast
10.2 Americas Parkinson's Disease Forecast by Country (2025-2030)
10.2.1 United States Parkinson's Disease Market Forecast
10.2.2 Canada Parkinson's Disease Market Forecast
10.2.3 Mexico Parkinson's Disease Market Forecast
10.2.4 Brazil Parkinson's Disease Market Forecast
10.3 APAC Parkinson's Disease Forecast by Region (2025-2030)
10.3.1 China Parkinson's Disease Market Forecast
10.3.2 Japan Parkinson's Disease Market Forecast
10.3.3 Korea Parkinson's Disease Market Forecast
10.3.4 Southeast Asia Parkinson's Disease Market Forecast
10.3.5 India Parkinson's Disease Market Forecast
10.3.6 Australia Parkinson's Disease Market Forecast
10.4 Europe Parkinson's Disease Forecast by Country (2025-2030)
10.4.1 Germany Parkinson's Disease Market Forecast
10.4.2 France Parkinson's Disease Market Forecast
10.4.3 UK Parkinson's Disease Market Forecast
10.4.4 Italy Parkinson's Disease Market Forecast
10.4.5 Russia Parkinson's Disease Market Forecast
10.5 Middle East & Africa Parkinson's Disease Forecast by Region (2025-2030)
10.5.1 Egypt Parkinson's Disease Market Forecast
10.5.2 South Africa Parkinson's Disease Market Forecast
10.5.3 Israel Parkinson's Disease Market Forecast
10.5.4 Turkey Parkinson's Disease Market Forecast
10.5.5 GCC Countries Parkinson's Disease Market Forecast
10.6 Global Parkinson's Disease Forecast by Type (2025-2030)
10.7 Global Parkinson's Disease Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Teva
11.1.1 Teva Company Information
11.1.2 Teva Parkinson's Disease Product Offered
11.1.3 Teva Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Teva Main Business Overview
11.1.5 Teva Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Parkinson's Disease Product Offered
11.2.3 Novartis Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Parkinson's Disease Product Offered
11.3.3 GSK Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 GSK Main Business Overview
11.3.5 GSK Latest Developments
11.4 AbbVie
11.4.1 AbbVie Company Information
11.4.2 AbbVie Parkinson's Disease Product Offered
11.4.3 AbbVie Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 AbbVie Main Business Overview
11.4.5 AbbVie Latest Developments
11.5 Merck
11.5.1 Merck Company Information
11.5.2 Merck Parkinson's Disease Product Offered
11.5.3 Merck Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Merck Main Business Overview
11.5.5 Merck Latest Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Information
11.6.2 Boehringer Ingelheim Parkinson's Disease Product Offered
11.6.3 Boehringer Ingelheim Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Boehringer Ingelheim Main Business Overview
11.6.5 Boehringer Ingelheim Latest Developments
11.7 Amneal + Impax
11.7.1 Amneal + Impax Company Information
11.7.2 Amneal + Impax Parkinson's Disease Product Offered
11.7.3 Amneal + Impax Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Amneal + Impax Main Business Overview
11.7.5 Amneal + Impax Latest Developments
11.8 Lundbeck
11.8.1 Lundbeck Company Information
11.8.2 Lundbeck Parkinson's Disease Product Offered
11.8.3 Lundbeck Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Lundbeck Main Business Overview
11.8.5 Lundbeck Latest Developments
11.9 Sun Pharma
11.9.1 Sun Pharma Company Information
11.9.2 Sun Pharma Parkinson's Disease Product Offered
11.9.3 Sun Pharma Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Sun Pharma Main Business Overview
11.9.5 Sun Pharma Latest Developments
11.10 Wockhardt
11.10.1 Wockhardt Company Information
11.10.2 Wockhardt Parkinson's Disease Product Offered
11.10.3 Wockhardt Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Wockhardt Main Business Overview
11.10.5 Wockhardt Latest Developments
11.11 UCB
11.11.1 UCB Company Information
11.11.2 UCB Parkinson's Disease Product Offered
11.11.3 UCB Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 UCB Main Business Overview
11.11.5 UCB Latest Developments
11.12 Bausch Health
11.12.1 Bausch Health Company Information
11.12.2 Bausch Health Parkinson's Disease Product Offered
11.12.3 Bausch Health Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Bausch Health Main Business Overview
11.12.5 Bausch Health Latest Developments
11.13 Acadia
11.13.1 Acadia Company Information
11.13.2 Acadia Parkinson's Disease Product Offered
11.13.3 Acadia Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Acadia Main Business Overview
11.13.5 Acadia Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Parkinson's Disease Market Size 2019-2030
2.1.2 Parkinson's Disease Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Parkinson's Disease Segment by Type
2.2.1 Carbidopa/Levodopa
2.2.2 Dopamine Receptor Agonists
2.2.3 MAO-Inhibitors
2.3 Parkinson's Disease Market Size by Type
2.3.1 Parkinson's Disease Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Parkinson's Disease Market Size Market Share by Type (2019-2024)
2.4 Parkinson's Disease Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.5 Parkinson's Disease Market Size by Application
2.5.1 Parkinson's Disease Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Parkinson's Disease Market Size Market Share by Application (2019-2024)
3 PARKINSON'S DISEASE MARKET SIZE BY PLAYER
3.1 Parkinson's Disease Market Size Market Share by Players
3.1.1 Global Parkinson's Disease Revenue by Players (2019-2024)
3.1.2 Global Parkinson's Disease Revenue Market Share by Players (2019-2024)
3.2 Global Parkinson's Disease Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PARKINSON'S DISEASE BY REGIONS
4.1 Parkinson's Disease Market Size by Regions (2019-2024)
4.2 Americas Parkinson's Disease Market Size Growth (2019-2024)
4.3 APAC Parkinson's Disease Market Size Growth (2019-2024)
4.4 Europe Parkinson's Disease Market Size Growth (2019-2024)
4.5 Middle East & Africa Parkinson's Disease Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Parkinson's Disease Market Size by Country (2019-2024)
5.2 Americas Parkinson's Disease Market Size by Type (2019-2024)
5.3 Americas Parkinson's Disease Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Parkinson's Disease Market Size by Region (2019-2024)
6.2 APAC Parkinson's Disease Market Size by Type (2019-2024)
6.3 APAC Parkinson's Disease Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Parkinson's Disease by Country (2019-2024)
7.2 Europe Parkinson's Disease Market Size by Type (2019-2024)
7.3 Europe Parkinson's Disease Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Parkinson's Disease by Region (2019-2024)
8.2 Middle East & Africa Parkinson's Disease Market Size by Type (2019-2024)
8.3 Middle East & Africa Parkinson's Disease Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PARKINSON'S DISEASE MARKET FORECAST
10.1 Global Parkinson's Disease Forecast by Regions (2025-2030)
10.1.1 Global Parkinson's Disease Forecast by Regions (2025-2030)
10.1.2 Americas Parkinson's Disease Forecast
10.1.3 APAC Parkinson's Disease Forecast
10.1.4 Europe Parkinson's Disease Forecast
10.1.5 Middle East & Africa Parkinson's Disease Forecast
10.2 Americas Parkinson's Disease Forecast by Country (2025-2030)
10.2.1 United States Parkinson's Disease Market Forecast
10.2.2 Canada Parkinson's Disease Market Forecast
10.2.3 Mexico Parkinson's Disease Market Forecast
10.2.4 Brazil Parkinson's Disease Market Forecast
10.3 APAC Parkinson's Disease Forecast by Region (2025-2030)
10.3.1 China Parkinson's Disease Market Forecast
10.3.2 Japan Parkinson's Disease Market Forecast
10.3.3 Korea Parkinson's Disease Market Forecast
10.3.4 Southeast Asia Parkinson's Disease Market Forecast
10.3.5 India Parkinson's Disease Market Forecast
10.3.6 Australia Parkinson's Disease Market Forecast
10.4 Europe Parkinson's Disease Forecast by Country (2025-2030)
10.4.1 Germany Parkinson's Disease Market Forecast
10.4.2 France Parkinson's Disease Market Forecast
10.4.3 UK Parkinson's Disease Market Forecast
10.4.4 Italy Parkinson's Disease Market Forecast
10.4.5 Russia Parkinson's Disease Market Forecast
10.5 Middle East & Africa Parkinson's Disease Forecast by Region (2025-2030)
10.5.1 Egypt Parkinson's Disease Market Forecast
10.5.2 South Africa Parkinson's Disease Market Forecast
10.5.3 Israel Parkinson's Disease Market Forecast
10.5.4 Turkey Parkinson's Disease Market Forecast
10.5.5 GCC Countries Parkinson's Disease Market Forecast
10.6 Global Parkinson's Disease Forecast by Type (2025-2030)
10.7 Global Parkinson's Disease Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Teva
11.1.1 Teva Company Information
11.1.2 Teva Parkinson's Disease Product Offered
11.1.3 Teva Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Teva Main Business Overview
11.1.5 Teva Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Parkinson's Disease Product Offered
11.2.3 Novartis Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Parkinson's Disease Product Offered
11.3.3 GSK Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 GSK Main Business Overview
11.3.5 GSK Latest Developments
11.4 AbbVie
11.4.1 AbbVie Company Information
11.4.2 AbbVie Parkinson's Disease Product Offered
11.4.3 AbbVie Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 AbbVie Main Business Overview
11.4.5 AbbVie Latest Developments
11.5 Merck
11.5.1 Merck Company Information
11.5.2 Merck Parkinson's Disease Product Offered
11.5.3 Merck Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Merck Main Business Overview
11.5.5 Merck Latest Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Information
11.6.2 Boehringer Ingelheim Parkinson's Disease Product Offered
11.6.3 Boehringer Ingelheim Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Boehringer Ingelheim Main Business Overview
11.6.5 Boehringer Ingelheim Latest Developments
11.7 Amneal + Impax
11.7.1 Amneal + Impax Company Information
11.7.2 Amneal + Impax Parkinson's Disease Product Offered
11.7.3 Amneal + Impax Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Amneal + Impax Main Business Overview
11.7.5 Amneal + Impax Latest Developments
11.8 Lundbeck
11.8.1 Lundbeck Company Information
11.8.2 Lundbeck Parkinson's Disease Product Offered
11.8.3 Lundbeck Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Lundbeck Main Business Overview
11.8.5 Lundbeck Latest Developments
11.9 Sun Pharma
11.9.1 Sun Pharma Company Information
11.9.2 Sun Pharma Parkinson's Disease Product Offered
11.9.3 Sun Pharma Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Sun Pharma Main Business Overview
11.9.5 Sun Pharma Latest Developments
11.10 Wockhardt
11.10.1 Wockhardt Company Information
11.10.2 Wockhardt Parkinson's Disease Product Offered
11.10.3 Wockhardt Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Wockhardt Main Business Overview
11.10.5 Wockhardt Latest Developments
11.11 UCB
11.11.1 UCB Company Information
11.11.2 UCB Parkinson's Disease Product Offered
11.11.3 UCB Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 UCB Main Business Overview
11.11.5 UCB Latest Developments
11.12 Bausch Health
11.12.1 Bausch Health Company Information
11.12.2 Bausch Health Parkinson's Disease Product Offered
11.12.3 Bausch Health Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Bausch Health Main Business Overview
11.12.5 Bausch Health Latest Developments
11.13 Acadia
11.13.1 Acadia Company Information
11.13.2 Acadia Parkinson's Disease Product Offered
11.13.3 Acadia Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Acadia Main Business Overview
11.13.5 Acadia Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Parkinson's Disease Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Carbidopa/Levodopa
Table 3. Major Players of Dopamine Receptor Agonists
Table 4. Major Players of MAO-Inhibitors
Table 5. Parkinson's Disease Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Parkinson's Disease Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Parkinson's Disease Market Size Market Share by Type (2019-2024)
Table 8. Parkinson's Disease Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Parkinson's Disease Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Parkinson's Disease Market Size Market Share by Application (2019-2024)
Table 11. Global Parkinson's Disease Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Parkinson's Disease Revenue Market Share by Player (2019-2024)
Table 13. Parkinson's Disease Key Players Head office and Products Offered
Table 14. Parkinson's Disease Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Parkinson's Disease Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Parkinson's Disease Market Size Market Share by Regions (2019-2024)
Table 19. Global Parkinson's Disease Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Parkinson's Disease Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Parkinson's Disease Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Parkinson's Disease Market Size Market Share by Country (2019-2024)
Table 23. Americas Parkinson's Disease Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Parkinson's Disease Market Size Market Share by Type (2019-2024)
Table 25. Americas Parkinson's Disease Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Parkinson's Disease Market Size Market Share by Application (2019-2024)
Table 27. APAC Parkinson's Disease Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Parkinson's Disease Market Size Market Share by Region (2019-2024)
Table 29. APAC Parkinson's Disease Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Parkinson's Disease Market Size Market Share by Type (2019-2024)
Table 31. APAC Parkinson's Disease Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Parkinson's Disease Market Size Market Share by Application (2019-2024)
Table 33. Europe Parkinson's Disease Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Parkinson's Disease Market Size Market Share by Country (2019-2024)
Table 35. Europe Parkinson's Disease Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Parkinson's Disease Market Size Market Share by Type (2019-2024)
Table 37. Europe Parkinson's Disease Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Parkinson's Disease Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Parkinson's Disease Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Parkinson's Disease Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Parkinson's Disease Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Parkinson's Disease Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Parkinson's Disease Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Parkinson's Disease Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Parkinson's Disease
Table 46. Key Market Challenges & Risks of Parkinson's Disease
Table 47. Key Industry Trends of Parkinson's Disease
Table 48. Global Parkinson's Disease Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Parkinson's Disease Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Parkinson's Disease Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Parkinson's Disease Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Teva Details, Company Type, Parkinson's Disease Area Served and Its Competitors
Table 53. Teva Parkinson's Disease Product Offered
Table 54. Teva Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Teva Main Business
Table 56. Teva Latest Developments
Table 57. Novartis Details, Company Type, Parkinson's Disease Area Served and Its Competitors
Table 58. Novartis Parkinson's Disease Product Offered
Table 59. Novartis Main Business
Table 60. Novartis Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Novartis Latest Developments
Table 62. GSK Details, Company Type, Parkinson's Disease Area Served and Its Competitors
Table 63. GSK Parkinson's Disease Product Offered
Table 64. GSK Main Business
Table 65. GSK Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. GSK Latest Developments
Table 67. AbbVie Details, Company Type, Parkinson's Disease Area Served and Its Competitors
Table 68. AbbVie Parkinson's Disease Product Offered
Table 69. AbbVie Main Business
Table 70. AbbVie Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. AbbVie Latest Developments
Table 72. Merck Details, Company Type, Parkinson's Disease Area Served and Its Competitors
Table 73. Merck Parkinson's Disease Product Offered
Table 74. Merck Main Business
Table 75. Merck Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Merck Latest Developments
Table 77. Boehringer Ingelheim Details, Company Type, Parkinson's Disease Area Served and Its Competitors
Table 78. Boehringer Ingelheim Parkinson's Disease Product Offered
Table 79. Boehringer Ingelheim Main Business
Table 80. Boehringer Ingelheim Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Boehringer Ingelheim Latest Developments
Table 82. Amneal + Impax Details, Company Type, Parkinson's Disease Area Served and Its Competitors
Table 83. Amneal + Impax Parkinson's Disease Product Offered
Table 84. Amneal + Impax Main Business
Table 85. Amneal + Impax Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Amneal + Impax Latest Developments
Table 87. Lundbeck Details, Company Type, Parkinson's Disease Area Served and Its Competitors
Table 88. Lundbeck Parkinson's Disease Product Offered
Table 89. Lundbeck Main Business
Table 90. Lundbeck Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Lundbeck Latest Developments
Table 92. Sun Pharma Details, Company Type, Parkinson's Disease Area Served and Its Competitors
Table 93. Sun Pharma Parkinson's Disease Product Offered
Table 94. Sun Pharma Main Business
Table 95. Sun Pharma Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Sun Pharma Latest Developments
Table 97. Wockhardt Details, Company Type, Parkinson's Disease Area Served and Its Competitors
Table 98. Wockhardt Parkinson's Disease Product Offered
Table 99. Wockhardt Main Business
Table 100. Wockhardt Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Wockhardt Latest Developments
Table 102. UCB Details, Company Type, Parkinson's Disease Area Served and Its Competitors
Table 103. UCB Parkinson's Disease Product Offered
Table 104. UCB Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. UCB Main Business
Table 106. UCB Latest Developments
Table 107. Bausch Health Details, Company Type, Parkinson's Disease Area Served and Its Competitors
Table 108. Bausch Health Parkinson's Disease Product Offered
Table 109. Bausch Health Main Business
Table 110. Bausch Health Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Bausch Health Latest Developments
Table 112. Acadia Details, Company Type, Parkinson's Disease Area Served and Its Competitors
Table 113. Acadia Parkinson's Disease Product Offered
Table 114. Acadia Main Business
Table 115. Acadia Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Acadia Latest Developments
Table 1. Parkinson's Disease Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Carbidopa/Levodopa
Table 3. Major Players of Dopamine Receptor Agonists
Table 4. Major Players of MAO-Inhibitors
Table 5. Parkinson's Disease Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Parkinson's Disease Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Parkinson's Disease Market Size Market Share by Type (2019-2024)
Table 8. Parkinson's Disease Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Parkinson's Disease Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Parkinson's Disease Market Size Market Share by Application (2019-2024)
Table 11. Global Parkinson's Disease Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Parkinson's Disease Revenue Market Share by Player (2019-2024)
Table 13. Parkinson's Disease Key Players Head office and Products Offered
Table 14. Parkinson's Disease Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Parkinson's Disease Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Parkinson's Disease Market Size Market Share by Regions (2019-2024)
Table 19. Global Parkinson's Disease Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Parkinson's Disease Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Parkinson's Disease Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Parkinson's Disease Market Size Market Share by Country (2019-2024)
Table 23. Americas Parkinson's Disease Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Parkinson's Disease Market Size Market Share by Type (2019-2024)
Table 25. Americas Parkinson's Disease Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Parkinson's Disease Market Size Market Share by Application (2019-2024)
Table 27. APAC Parkinson's Disease Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Parkinson's Disease Market Size Market Share by Region (2019-2024)
Table 29. APAC Parkinson's Disease Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Parkinson's Disease Market Size Market Share by Type (2019-2024)
Table 31. APAC Parkinson's Disease Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Parkinson's Disease Market Size Market Share by Application (2019-2024)
Table 33. Europe Parkinson's Disease Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Parkinson's Disease Market Size Market Share by Country (2019-2024)
Table 35. Europe Parkinson's Disease Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Parkinson's Disease Market Size Market Share by Type (2019-2024)
Table 37. Europe Parkinson's Disease Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Parkinson's Disease Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Parkinson's Disease Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Parkinson's Disease Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Parkinson's Disease Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Parkinson's Disease Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Parkinson's Disease Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Parkinson's Disease Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Parkinson's Disease
Table 46. Key Market Challenges & Risks of Parkinson's Disease
Table 47. Key Industry Trends of Parkinson's Disease
Table 48. Global Parkinson's Disease Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Parkinson's Disease Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Parkinson's Disease Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Parkinson's Disease Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Teva Details, Company Type, Parkinson's Disease Area Served and Its Competitors
Table 53. Teva Parkinson's Disease Product Offered
Table 54. Teva Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Teva Main Business
Table 56. Teva Latest Developments
Table 57. Novartis Details, Company Type, Parkinson's Disease Area Served and Its Competitors
Table 58. Novartis Parkinson's Disease Product Offered
Table 59. Novartis Main Business
Table 60. Novartis Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Novartis Latest Developments
Table 62. GSK Details, Company Type, Parkinson's Disease Area Served and Its Competitors
Table 63. GSK Parkinson's Disease Product Offered
Table 64. GSK Main Business
Table 65. GSK Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. GSK Latest Developments
Table 67. AbbVie Details, Company Type, Parkinson's Disease Area Served and Its Competitors
Table 68. AbbVie Parkinson's Disease Product Offered
Table 69. AbbVie Main Business
Table 70. AbbVie Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. AbbVie Latest Developments
Table 72. Merck Details, Company Type, Parkinson's Disease Area Served and Its Competitors
Table 73. Merck Parkinson's Disease Product Offered
Table 74. Merck Main Business
Table 75. Merck Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Merck Latest Developments
Table 77. Boehringer Ingelheim Details, Company Type, Parkinson's Disease Area Served and Its Competitors
Table 78. Boehringer Ingelheim Parkinson's Disease Product Offered
Table 79. Boehringer Ingelheim Main Business
Table 80. Boehringer Ingelheim Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Boehringer Ingelheim Latest Developments
Table 82. Amneal + Impax Details, Company Type, Parkinson's Disease Area Served and Its Competitors
Table 83. Amneal + Impax Parkinson's Disease Product Offered
Table 84. Amneal + Impax Main Business
Table 85. Amneal + Impax Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Amneal + Impax Latest Developments
Table 87. Lundbeck Details, Company Type, Parkinson's Disease Area Served and Its Competitors
Table 88. Lundbeck Parkinson's Disease Product Offered
Table 89. Lundbeck Main Business
Table 90. Lundbeck Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Lundbeck Latest Developments
Table 92. Sun Pharma Details, Company Type, Parkinson's Disease Area Served and Its Competitors
Table 93. Sun Pharma Parkinson's Disease Product Offered
Table 94. Sun Pharma Main Business
Table 95. Sun Pharma Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Sun Pharma Latest Developments
Table 97. Wockhardt Details, Company Type, Parkinson's Disease Area Served and Its Competitors
Table 98. Wockhardt Parkinson's Disease Product Offered
Table 99. Wockhardt Main Business
Table 100. Wockhardt Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Wockhardt Latest Developments
Table 102. UCB Details, Company Type, Parkinson's Disease Area Served and Its Competitors
Table 103. UCB Parkinson's Disease Product Offered
Table 104. UCB Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. UCB Main Business
Table 106. UCB Latest Developments
Table 107. Bausch Health Details, Company Type, Parkinson's Disease Area Served and Its Competitors
Table 108. Bausch Health Parkinson's Disease Product Offered
Table 109. Bausch Health Main Business
Table 110. Bausch Health Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Bausch Health Latest Developments
Table 112. Acadia Details, Company Type, Parkinson's Disease Area Served and Its Competitors
Table 113. Acadia Parkinson's Disease Product Offered
Table 114. Acadia Main Business
Table 115. Acadia Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Acadia Latest Developments
LIST OF FIGURES
Figure 1. Parkinson's Disease Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Parkinson's Disease Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Parkinson's Disease Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Parkinson's Disease Sales Market Share by Country/Region (2023)
Figure 8. Parkinson's Disease Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Parkinson's Disease Market Size Market Share by Type in 2023
Figure 10. Parkinson's Disease in Hospitals
Figure 11. Global Parkinson's Disease Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Parkinson's Disease in Clinics
Figure 13. Global Parkinson's Disease Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Global Parkinson's Disease Market Size Market Share by Application in 2023
Figure 15. Global Parkinson's Disease Revenue Market Share by Player in 2023
Figure 16. Global Parkinson's Disease Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Parkinson's Disease Market Size 2019-2024 ($ Millions)
Figure 18. APAC Parkinson's Disease Market Size 2019-2024 ($ Millions)
Figure 19. Europe Parkinson's Disease Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Parkinson's Disease Market Size 2019-2024 ($ Millions)
Figure 21. Americas Parkinson's Disease Value Market Share by Country in 2023
Figure 22. United States Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Parkinson's Disease Market Size Market Share by Region in 2023
Figure 27. APAC Parkinson's Disease Market Size Market Share by Type in 2023
Figure 28. APAC Parkinson's Disease Market Size Market Share by Application in 2023
Figure 29. China Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Parkinson's Disease Market Size Market Share by Country in 2023
Figure 36. Europe Parkinson's Disease Market Size Market Share by Type (2019-2024)
Figure 37. Europe Parkinson's Disease Market Size Market Share by Application (2019-2024)
Figure 38. Germany Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Parkinson's Disease Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Parkinson's Disease Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Parkinson's Disease Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 52. APAC Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 53. Europe Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 55. United States Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 56. Canada Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 59. China Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 60. Japan Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 61. Korea Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 63. India Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 64. Australia Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 65. Germany Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 66. France Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 67. UK Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 68. Italy Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 69. Russia Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 70. Spain Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 73. Israel Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 76. Global Parkinson's Disease Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Parkinson's Disease Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Parkinson's Disease Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Parkinson's Disease Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Parkinson's Disease Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Parkinson's Disease Sales Market Share by Country/Region (2023)
Figure 8. Parkinson's Disease Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Parkinson's Disease Market Size Market Share by Type in 2023
Figure 10. Parkinson's Disease in Hospitals
Figure 11. Global Parkinson's Disease Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Parkinson's Disease in Clinics
Figure 13. Global Parkinson's Disease Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Global Parkinson's Disease Market Size Market Share by Application in 2023
Figure 15. Global Parkinson's Disease Revenue Market Share by Player in 2023
Figure 16. Global Parkinson's Disease Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Parkinson's Disease Market Size 2019-2024 ($ Millions)
Figure 18. APAC Parkinson's Disease Market Size 2019-2024 ($ Millions)
Figure 19. Europe Parkinson's Disease Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Parkinson's Disease Market Size 2019-2024 ($ Millions)
Figure 21. Americas Parkinson's Disease Value Market Share by Country in 2023
Figure 22. United States Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Parkinson's Disease Market Size Market Share by Region in 2023
Figure 27. APAC Parkinson's Disease Market Size Market Share by Type in 2023
Figure 28. APAC Parkinson's Disease Market Size Market Share by Application in 2023
Figure 29. China Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Parkinson's Disease Market Size Market Share by Country in 2023
Figure 36. Europe Parkinson's Disease Market Size Market Share by Type (2019-2024)
Figure 37. Europe Parkinson's Disease Market Size Market Share by Application (2019-2024)
Figure 38. Germany Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Parkinson's Disease Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Parkinson's Disease Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Parkinson's Disease Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Parkinson's Disease Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 52. APAC Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 53. Europe Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 55. United States Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 56. Canada Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 59. China Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 60. Japan Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 61. Korea Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 63. India Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 64. Australia Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 65. Germany Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 66. France Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 67. UK Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 68. Italy Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 69. Russia Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 70. Spain Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 73. Israel Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Parkinson's Disease Market Size 2025-2030 ($ Millions)
Figure 76. Global Parkinson's Disease Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Parkinson's Disease Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Pyrantel Market Growth 2023-2029
US$ 3,660.00
February 2023
119 pages
Global Xatmep Market Growth 2024-2030
US$ 3,660.00
December 2024
82 pages
Global Medical Radiation Detectors Market Growth 2023-2029
US$ 3,660.00
February 2023
95 pages
Global Hepatitis Test Kits Market Growth 2024-2030
US$ 3,660.00
November 2024
92 pages
Global Autism Spectrum Disorder (ASD) Treatment Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
September 2024
91 pages
